Flexible Stenting Solutions, Inc. Announces First Impant of the 200mm FlexStent Femoropopliteal Self Expanding Stent System
EATONTOWN, NJ --Flexible Stenting Solutions, Inc. (FSS), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today the successful implantation of its 200 mm FlexStent® Femoropopliteal Self Expanding Stent System by Dr. Andrew Holden at Auckland City Hospital in New Zealand. With the addition of the 200 mm length FlexStent® Femoropopliteal Self Expanding Stent System under CE Mark (Conformite Europeene), stent sizes now include a complete matrix of 5, 6, 7 and 8 mm diameters with lengths ranging from 30 to 200 mm in a 6 French delivery system.
Dr. Andrew Holden, Associate Professor and Director of Interventional Radiology at Auckland City Hospital, had conducted FSS' first-in-man study of the FlexStent® in 2009. In yesterday's procedure, he implanted a 6 mm diameter x 200 mm long FlexStent® followed by overlapping a 6x150 mm and a 6x40 mm stents to treat a long, diffuse lesion in the patient's femoropopliteal artery. Dr. Holden commented, "The 200 mm FlexStent® was able to be deployed across the aortic bifurcation in the contralateral SFA easily and accurately with an excellent imaging and clinical result."
During the procedure, Dr. Holden was accompanied by Bradley Beach, FSS' VP of R&D and co-inventor of the FlexStent® technology. Mr. Beach added, "I was thrilled to see the confidence in which Dr. Holden used our devices for this procedure. His feedback in the 2009 first-in-man trial was instrumental in our designing the current low-deployment force system."
Dr. Holden is scheduled to transmit a live case using the FlexStent® at the TCT Conference in San Francisco on Wednesday, November 9th, 2011.
Source: Business Wire, Flexible Stent Solutions
Flexible Stenting Solutions, Inc. Announces First Impant of the 200mm FlexStent Femoropopliteal Self Expanding Stent System
- Log in to post comments
Comments